revvity.com - Utang jangka cendhak perusahaan RVTY

Revvity, Inc. (RVTY) develops advanced tools for genomic research, complementing them with newborn analysis equipment based on a recurring consumables sales model. The total amount of short-term debt illustrates the current debt load, where the 0.24 level captures the latest values. Patents for prenatal screening and high switching costs for clinics migrating to other platforms ensure a stable income stream.

Revvity, Inc. (RVTY) is actively integrating high-precision automated assembly and quality control lines into its production cycles. These investments necessitate monitoring of current liabilities, which track the total amount of debt maturing within one year. An increase in this metric signals a risk of liquidity shortages. The stable trend on this chart confirms the issuer's financial stability, ensuring that share value is protected from cash flow gaps.